Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Ex-vivo Perfusion and Ventilation of Lungs Recovered From Non-Heart-Beating Donors to Assess Transplant Suitability

This study has suspended participant recruitment.
(Funding suspended, currently seeking other funding source(s).)
Duke University
National Heart, Lung, and Blood Institute (NHLBI)
XVIVO Perfusion
Information provided by (Responsible Party):
Tom Egan, MD,MsC, University of North Carolina, Chapel Hill Identifier:
First received: June 6, 2012
Last updated: July 8, 2016
Last verified: July 2016
No Study Results Posted on for this Study
  Study Status: This study has suspended participant recruitment.
  Estimated Study Completion Date: July 2018
  Estimated Primary Completion Date: July 2017 (Final data collection date for primary outcome measure)